RENO Dr. Sanford Barsky, chair of pathology at the University of Nevada School of Medicine, is researching breast cancer latency, that period of time when the symptoms of the cancer begin to present themselves to the time it has been successfully treated.

In one of only two studies of its kind, a study from researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts demonstrates that non-viral gene therapy can delay the onset of some forms of eye disease and preserve vision. The team developed nanoparticles to deliver therapeutic genes to the retina and found that treated mice temporarily …

( Albert Einstein College of Medicine ) Albert Einstein College of Medicine of Yeshiva University has been named one of the National Institutes of Health’s Nathan Shock Centers of Excellence in the Basic Biology of Aging.

Discovery furthers knowledge of microRNA’s role in diseaseResearchers at Tufts University School of Medicine and Tufts Medical Center have identified an RNA sequence that promotes increased numbers of specific microRNAs (miRNAs), molecules that regulate cell growth, development, and stress response. The discovery helps researchers understand the links between miRNA expression and disease …

Researchers from Mount Sinai School of Medicine have for the first time developed a way to visualize coronary artery plaques vulnerable to rupture using multi-color computed tomography (CT), an innovation that will lead to better and earlier diagnosis of cardiovascular disease. The data are published in the September issue of Radiology.Ruptures of atherosclerotic plaques are the cause of nearly …

Researchers at Tufts University School of Medicine and Tufts Medical Center have identified an RNA sequence that promotes increased numbers of specific microRNAs (miRNAs), molecules that regulate cell growth, development, and stress response. The discovery helps researchers understand the links between miRNA expression and disease, including heart disease and cancer. The findings are published …

Personalized medicine the crossroads at which biotechnology, genomics, and medical treatment meet is a concept that is often touted, though rarely seen in action. As with any radical idea, there needs to be a proving ground before it achieves wider acceptance among professionals and the public.

The University of Nevada is celebrating improvements on their campus with the opening of a new research facility.

With the grand opening Monday of the Center for Molecular Medicine at the University of Nevada, Reno, the world has gained another powerful weapon in the fight against diseases that cripple and kill millions of people every year, one of the new centers key researchers said.

After years of planning and fundraising, the Center for Molecular Medicine has opened its doors at the University of Nevada Medical School on the UNR campus.

Antibiotics are a bedrock of modern medicine; but in the very near future, we’re going to have to learn to live without them once again. And it’s going to get nasty.

A study published in the August Journal of Nuclear Medicine (JNM) finds that molecular imaging-a non-invasive imaging procedure-can identify high-risk patients with potentially life-threatening cardiovascular conditions and help physicians determine which patients are best suited for implantable cardioverter defibrillator (ICD) therapy.

( Society of Nuclear Medicine ) A study published in the August Journal of Nuclear Medicine finds that molecular imaging — a noninvasive imaging procedure — can identify high-risk patients with potentially life-threatening cardiovascular conditions and help physicians determine which patients are best suited for implantable cardioverter defibrillator therapy.

( American Society for Microbiology ) Manuela Raffatellu, M.D., assistant professor, Department of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, has been chosen by the American Society for Microbiology to receive a 2010 ICAAC Young Investigator Award. Sponsored by the ASM, this award recognizes an early career scientist for research excellence in …

Spartan Bioscience Inc., a privately held molecular diagnostics company that develops, manufactures, and markets DNA testing systems for on-demand applications, today announced the availability of the Spartan RX, the first complete sample-to-result, point-of-care DNA testing system for personalized medicine. The non-invasive and easy-to-use system provides automated results in one hour, enabling …

Manuela Raffatellu, M.D., Assistant Professor, Department of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, has been chosen by the American Society for Microbiology (ASM) to receive a 2010 ICAAC Young Investigator Award. Sponsored by the ASM, this award recognizes an early career scientist for research excellence in microbiology and infectious diseases …

( University of Maryland Medical Center ) The University of Maryland School of Medicine has received a $7.9 million NIH grant to acquire a superconducting 950 MHz Nuclear Magnetic Resonance magnet that will help researchers unravel the mysteries of molecules and develop new agents to treat cancer, AIDS and other diseases. The University of Maryland will be the only academic institution in the …

The University of Maryland School of Medicine has received a $7.9 million federal grant to acquire a superconducting 950 MHz Nuclear Magnetic Resonance (NMR) magnet that will help researchers unravel the mysteries of molecules and develop new agents to treat cancer, AIDS and other diseases. The grant is among the largest of its kind ever awarded by the National Center for Research Resources …

A second-generation cancer drug that targets patients’ specific molecular defects is showing encouraging results in early clinical trials, according to a study published in the latest edition of the Journal of Clinical Oncology. Researchers from the Drug Development Unit at The Institute of Cancer Research (ICR) and The Royal Marsden NHS Foundation Trust led a Phase I clinical trial of the drug …

A study published in the August Journal of Nuclear Medicine (JNM) finds that molecular imaging – a non-invasive imaging procedure – can identify high-risk patients with potentially life-threatening cardiovascular conditions and help physicians determine which patients are best suited for implantable cardioverter defibrillator (ICD) therapy. “If the molecular imaging techniques are used for …